Bioalpha Holdings Bhd (XKLS:0179) Accounts Payable: RM0.48 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bioalpha Holdings Bhd Accounts Payable?

Bioalpha Holdings Bhd XKLS:0179 Accounts Payable is RM0.48 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Bioalpha Holdings Bhd's Accounts Payable for the quarter that ended in Mar. 2026 was RM0.48 Mil.

Bioalpha Holdings Bhd's quarterly Accounts Payable increased from Sep. 2025 (RM0.47 Mil) to Dec. 2025 (RM0.60 Mil) but then declined from Dec. 2025 (RM0.60 Mil) to Mar. 2026 (RM0.48 Mil).

Bioalpha Holdings Bhd's annual Accounts Payable declined from Dec. 2023 (RM4.11 Mil) to Dec. 2024 (RM1.92 Mil) and declined from Dec. 2024 (RM1.92 Mil) to Dec. 2025 (RM0.60 Mil).

Bioalpha Holdings Bhd Accounts Payable Related Terms

Bioalpha Holdings Bhd Accounts Payable Historical Data

* Premium members only.

The historical data trend for Bioalpha Holdings Bhd's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioalpha Holdings Bhd Accounts Payable Chart

Bioalpha Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.51 4.79 4.11 1.92 0.60

Bioalpha Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.75 0.47 0.60 0.48

Bioalpha Holdings Bhd Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of RM0.48 Mil mean?
Bioalpha Holdings Bhd (XKLS:0179) has a Accounts Payable of RM0.48 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Bioalpha Holdings Bhd and its competitors.
Is Bioalpha Holdings Bhd's Accounts Payable too high?
Bioalpha Holdings Bhd's current Accounts Payable is RM0.48 Mil.
How does Bioalpha Holdings Bhd's Accounts Payable compare to KHC and GIS?
Bioalpha Holdings Bhd's Accounts Payable of RM0.48 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Consumer Packaged Goods company?
A good Accounts Payable depends on the Consumer Packaged Goods industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Bioalpha Holdings Bhd and its competitors. Bioalpha Holdings Bhd's current Accounts Payable is RM0.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioalpha Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Bioalpha Holdings Bhd (XKLS:0179) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.02 — trading 100% above its estimated fair value. The current Accounts Payable is RM0.48 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Bioalpha Holdings Bhd (XKLS:0179), the current Accounts Payable is RM0.48 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioalpha Holdings Bhd Business Description

Address No. 1, Jalan Perindustrian Suntrack, Hub Perindustrian Suntrack, Bandar Baru Bangi, Off Jalan P1A, Seksyen 13, Kajang, SGR, MYS, 43000
Bioalpha Holdings Bhd is a nutraceutical and health supplement group in Malaysia, operates a multi-faceted value chain that includes agricultural development, research and development (R&D), and the manufacturing of functional food and supplement products on an Original Design Manufacturer (ODM) basis. The business operates in segments that include Trading, Manufacturing, Retail pharmacy, and Others. It generates maximum revenue from Manufacturing segment, which involves Research, development, manufacture, importer, exporter, distribution and trader of nutritional and health care products. Geographically, the company derives majority revenue from Malaysia, while it also has its presence in China and Others.